Intas and Henlius receive positive CHMP opinion for HETRONIFLY® (HANSIZHUANG in China) as first-line treatment for extensive-stage small cell lung cancer

Sep 25, 2024

Ahmedabad (Gujarat) [India], September 25: Intas Pharmaceuticals Limited ("Intas") has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...

Himachal Assembly adopt resolution for legal cannabis cultivation in state

Sep 06, 2024

The committee proposed the cultivation of cannabis for medicinal and industrial purposes, highlighting its potential as an economic asset for the state.

Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA

Aug 01, 2024

Singapore, August 1: Prestige Biopharma, a pioneer in biopharmaceuticals, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

Trade in medicinal, pharma products reached new peak in 2022: Eurostat

Apr 25, 2023

Exports increased from EUR 50 billion in 2002 to EUR 287 billion in 2022. Compared with 2021 (EUR 235 billion), the 2022 total represented...

National Medicinal Plants Board launches consortia for medicinal plants

Dec 28, 2020

New Delhi [India], December 28 : The National Medicinal Plants Board (NMPB) on Monday launched consortia for medicinal plants to deliberate on quality planting...

Study reveals people who use cannabis are more prone to consume nicotine products

Aug 24, 2022

Washington [US], August 24 : According to a study, people who use medicinal cannabis are more prone than the general population to consume nicotine...